Cargando…
Suppression of Sost/Sclerostin and Dickkopf‐1 Augment Intervertebral Disc Structure in Mice
Intervertebral disc (IVD) degeneration is a leading cause of low back pain, characterized by accelerated extracellular matrix breakdown and IVD height loss, but there is no approved pharmacological therapeutic. Deletion of Wnt ligand competitor Lrp5 induces IVD degeneration, suggesting that Wnt sign...
Autores principales: | Kroon, Tori, Bhadouria, Neharika, Niziolek, Paul, Edwards, Daniel, Choi, Roy, Clinkenbeard, Erica L, Robling, Alexander, Holguin, Nilsson |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320845/ https://www.ncbi.nlm.nih.gov/pubmed/35278242 http://dx.doi.org/10.1002/jbmr.4546 |
Ejemplares similares
-
Raloxifene Stimulates Estrogen Signaling to Protect Against Age- and Sex-Related Intervertebral Disc Degeneration in Mice
por: Bhadouria, Neharika, et al.
Publicado: (2022) -
Expression of SOST/sclerostin in compressed periodontal ligament cells
por: Ueda, Masae, et al.
Publicado: (2016) -
Lumbar endplate microfracture injury induces Modic-like changes, intervertebral disc degeneration and spinal cord sensitization – An In Vivo Rat Model
por: Wang, Dalin, et al.
Publicado: (2023) -
SOST/Sclerostin Improves Posttraumatic Osteoarthritis and Inhibits MMP2/3 Expression After Injury
por: Chang, Jiun C, et al.
Publicado: (2018) -
Lipid Nanoparticle Delivery of siRNA to Osteocytes Leads to Effective Silencing of SOST and Inhibition of Sclerostin In Vivo
por: Basha, Genc, et al.
Publicado: (2016)